Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung

Annals of Thoracic Surgery

Volumn 66, Issue 4, 1998, Pages 1159-1163

  Hsieh, Chih Cheng ^a   Chow, Kuan Chih ^a   Fahn, Huei Jyh ^a   Tsai, Chun Ming ^a   Li, Wing Yin ^a   Huang, Min Hsiung ^a   Wang, Liang Shun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ADULT; AGED; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG RESECTION; MALE; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032191181     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00792-9     Document Type: Conference Paper

References (22)

1. 1. Annual reports of the Department of Health, Executive Yuan, Republic of China, 1995.
2. 2. Melamed MR, Flehinger BJ, Zaman MB. Impact of early detection on the clinical course of lung cancer. Surg Clin North Am 1987;67:909-24.
3. 3. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984;38:331-6.
4. 4. Volm M, Effereth T, Mattern J. Oncoprotein (c-myc, c-erbB-1, c-erbB-2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res 1992;12:11-20.
5. 5. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, Nico van Zandwijk, Bos JL. Mutational activity of the K-ras oncogene: a possible pathogenic factor in adenocarcinoma of the lung. N Engl J Med 1987;317:929-35.
6. 6. Schneider PM, Hung MC, Chiocca SM, et al. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res 1989;49:4968-71.
7. 7. Kern JA, Schwarts DA, Nordberg JE, et al. P185neu expression in human lung adenocarcinoma predicts shortened survival. Cancer Res 1990;50:5184-91.
8. 8. Weiner DB, Nordberg J, Robinson R, et al. Expression of the neu gene-encoded protein (p185neu) in human non-small cell carcinomas of the lung. Cancer Res 1990;50:421-31.
9. 9. Shi D, He G, Cao S, et al. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer. Mol Carcinogen 1992;5:213-8.
10. 10. Harpole DH Jr, Herndon JE II, Wolfe WG, Iglehart JD, Marks JR. A prognostic model of recurrent and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995;55: 51-6.
11. 11. Coussens L, Yang-Feng TL, Liao YC, et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985;230: 1132-9.
12. 12. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986;232: 1644-6.
13. 13. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the erbB-2/neu oncogene. Science 1987;235:177-82.
14. 14. Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1994;1198:165-84.
15. 15. Tsai CM, Chang KT, Perng RP, et al. Correlation of intrinsic chemoresistance of non-small cell lung cancer lines with HER-2/neu gene expression but not with ras gene mutations. J Natl Cancer Inst 1993;85:897-901.
16. 16. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-33S.
17. 17. Osaki T, Mitsudomi T, Oyama T, et al. Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. Chest 1995;108:157-62.
18. neu protein in non-small-cell lung cancer tissue. Br J Cancer 1997;75:684-9.
19. 19. Dittadi R, Donisi PM, Brazzale A, et al. Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationship with clinical and biochemical parameters. Anticancer 1992;12:2005-10.
20. neu expressing non-small cell lung cancer cells. Cancer Res 1996;56:1068-74.
21. 21. Tsai CM, Perng RP, Chen MM, et al. Greater enhancement of chemosensitivity by caffeine in high p185neu expression human non-small cell lung cancer cell lines. J Natl Cancer Inst 1994;86:1018-20.
22. 22. Tsai CM, Chang KT, Chen JY, et al. Cytotoxic effects of gemcitabine-containing regimens against human non-small cell lung cancer cell lines which express different levels of p185neu. Cancer Res 1996;56:794-801.